New recommendation on Metformin out from @CochraneCanada CANPCC guideline on Long COVID Post -COVID condition. Conditional recommendation in favor of using Metformin for people with COVID-19 infection to prevent Post-COVID Condition/Long Covid/PASC. It could prevent 41/1,000 cases of Long Covid. Very important for primary care practice.
Outpatient treatment of COVID-19 and incidence of post-COVID-19 condition over 10 months (COVID-OUT): a multicentre, randomised, quadruple-blind, parallel-group, phase 3 trial
Post-COVID-19 condition (also known as long COVID) is an emerging chronic illness potentially affecting millions of people. We aimed to evaluate whether outpatient COVID-19 treatment with metformin, ivermectin, or fluvoxamine soon after SARS-CoV-2 infection could reduce the risk of long COVID.
Post-COVID-19 condition (also known as long COVID) is an emerging chronic illness potentially affecting millions of people. We aimed to evaluate whether outpatient COVID-19 treatment with metformin, ivermectin, or fluvoxamine soon after SARS-CoV-2 infection could reduce the risk of long COVID.
A clinical trial showed metformin reduced risk of #LongCovid by ~41% when taken during acute #covid! Access #metformin (covid study dosing) easier here:
